AAAAAA

   
Results: 1-9 |
Results: 9
Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer
Authors: Boadas, J Mora, J Urgell, E Puig, P Roca, M Cusso, X Capella, G Luis, F Farre, A
Citation: J. Boadas et al., Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer, EUR J GASTR, 13(10), 2001, pp. 1153-1159
Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-ras
Authors: Lohr, M Muller, P Zauner, I Schmidt, C Trautmann, B Thevenod, F Capella, G Farre, A Liebe, S Jesnowski, R
Citation: M. Lohr et al., Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-ras, VIRCHOWS AR, 438(6), 2001, pp. 581-590
Generation of helper and cytotoxic CD4+T cell clones specific for the minor histocompatibility antigen H-Y, after in vitro priming of human T cells by HLA-identical monocyte-derived dendritic cells
Authors: Eljaafari, A Farre, A Duperrier, K Even, J Vie, H Michallet, M Souillet, G Freidel, AC Gebuhrer, L Rigal, D
Citation: A. Eljaafari et al., Generation of helper and cytotoxic CD4+T cell clones specific for the minor histocompatibility antigen H-Y, after in vitro priming of human T cells by HLA-identical monocyte-derived dendritic cells, TRANSPLANT, 71(10), 2001, pp. 1449-1455
The novel analgesic, cizolirtine, inhibits the spinal release of substanceP and CGRP in rats
Authors: Ballet, S Aubel, B Mauborgne, A Polienor, H Farre, A Cesselin, F Hamon, P Bourgoin, AS
Citation: S. Ballet et al., The novel analgesic, cizolirtine, inhibits the spinal release of substanceP and CGRP in rats, NEUROPHARM, 40(4), 2001, pp. 578-589
p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis
Authors: Lohr, M Muller, P Mora, J Brinkmann, B Ostwald, C Farre, A Lluis, F Adam, U Stubbe, J Plath, F Nizze, H Hopt, UT Barten, M Capella, G Liebe, S
Citation: M. Lohr et al., p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis, GASTROIN EN, 53(7), 2001, pp. 734-743
Survival of cancer of the pancreas. Bases for new strategies in diagnosis and therapy
Authors: Boadas, J Balart, J Capella, G Lluis, F Farre, A
Citation: J. Boadas et al., Survival of cancer of the pancreas. Bases for new strategies in diagnosis and therapy, REV ESP E D, 92(5), 2000, pp. 321-325
Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer
Authors: Urgell, E Puig, P Boadas, J Capella, G Queralto, JM Boluda, R Antonijuan, A Farre, A Lluis, F Gonzalez-Sastre, F Mora, J
Citation: E. Urgell et al., Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer, EUR J CANC, 36(16), 2000, pp. 2069-2075
A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer
Authors: Puig, P Urgell, E Capella, G Sancho, FJ Pujol, J Boadas, J Farre, A Lluis, F Gonzalez-Sastre, F Mora, J
Citation: P. Puig et al., A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer, INT J CANC, 85(1), 2000, pp. 73-77
K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: Diagnostic utility and prognostic significance
Authors: Castells, A Puig, P Mora, J Boadas, J Boix, L Urgell, E Sole, M Capella, G Lluis, F Fernandez-Cruz, L Navarro, S Farre, A
Citation: A. Castells et al., K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: Diagnostic utility and prognostic significance, J CL ONCOL, 17(2), 1999, pp. 578-584
Risultati: 1-9 |